Navigation Links
Leading Biotechnology Company Grows with StayinFront CRM
Date:10/4/2007

- StayinFront's Ability to Support Expanding Customer Base and Complex

Business Processes Cited as Critical to Decision -

FAIRFIELD, N.J., Oct. 4 /PRNewswire/ StayinFront, Inc., a global provider of enterprise wide customer relationship management (CRM) applications, decision support tools, data services and eBusiness systems, today announced that a leading biotechnology company signed a three-year agreement selecting StayinFront CRM Version 10 as its customer relationship management system for its U.S.-based operations. The agreement includes a range of support services from StayinFront.

The company has a global workforce of close to 18,000 and is represented in more than 120 countries. Balancing their customer relationship management needs with the highly dynamic nature of their industry, as well as complex data requirements, led them to evaluate a wide range of leading CRM packages, including traditional ERP solutions and those from "dot-com" providers. StayinFront CRM was selected because in addition to providing CRM capabilities to the biotechnology company's sales force, StayinFront could also support the marketing and field service organizations.

"This client understands the true success factors for CRM and we're honored that their careful analysis of CRM vendors led them to choose StayinFront. This new collaboration in the United States market, added to our existing relationship with them in Canada, makes this a key North American partnership for both companies," said Ken Arbadji, vice president of North American sales for StayinFront.

About StayinFront CRM

Designed to provide a single technology platform that manages and integrates all aspects of customer interaction, including sales, marketing, and customer support, StayinFront CRM is an enterprise-wide "exact fit" solution. Rapidly configured to meet the specific needs of each client, StayinFront CRM's unique product architecture can integrate into exis
'/>"/>

SOURCE StayinFront, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Visions, Part II: Preizler sees IT leading incremental health system change
2. Waisman director leading early stages of the Wisconsin Institutes for Discovery
3. NimbleGen partners with leading researchers
4. Leading global Big Pharma companies of 2005
5. Leading cancer institute to install three TomoTherapy systems
6. The worlds leading biotech companies
7. Olympics of biotechnology has international flavor
8. Making Wisconsin the biotechnology leader
9. Let the olympics of biotechnology in the Midwest begin!
10. The mushrooming of biotechnology in the U.S.
11. 42 days until the 2006 Olympics of Biotechnology in Chicago
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Feb. 27, 2015  Pharmacyclics, Inc. (NASDAQ: ... studies for its newly developed Bruton,s tyrosine kinase ... been completed. The results of these preclinical evaluations ... Drug Administration. The feedback received from the Agency ... first-in-human study. Additional preclinical work is required to ...
(Date:2/27/2015)... Bionomics Limited (ASX:BNO, ADR:BMICY) is to present ... in patients with metastatic renal cancer at the ASCO ... . The data will be presented by Dr. ... Cancer Center in California in ... identifies Ferritin and IL-8 as two baseline biomarkers that ...
(Date:2/27/2015)... , Feb. 27, 2015   PureTech , a ... and commercializing disruptive products and technologies in the healthcare ... , former CEO and Member of the Board of ... "It,s has been a pleasure to know ... that we will be working together more closely now," ...
(Date:2/26/2015)... LEXINGTON, Mass., Feb. 26, 2015   Synageva ... a biopharmaceutical company developing therapeutic products for rare ... and provided 2015 goals, other key objectives, and ... conference call today at 4:30 p.m. EST to ... business update.  To participate in today,s call by ...
Breaking Biology Technology:Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 2New BNC105 Biomarker Data to be Presented at US Cancer Conference 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 4New BNC105 Biomarker Data to be Presented at US Cancer Conference 5Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 2Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 3Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 4Synageva BioPharma Reports 2014 Full Year Financial Results 2Synageva BioPharma Reports 2014 Full Year Financial Results 3Synageva BioPharma Reports 2014 Full Year Financial Results 4Synageva BioPharma Reports 2014 Full Year Financial Results 5Synageva BioPharma Reports 2014 Full Year Financial Results 6Synageva BioPharma Reports 2014 Full Year Financial Results 7Synageva BioPharma Reports 2014 Full Year Financial Results 8Synageva BioPharma Reports 2014 Full Year Financial Results 9
... AMDL, Inc. (Amex:,ADL), headquartered in Tustin, California, ... through its wholly owned subsidiary Jade,Pharmaceutical Inc., ... with JPI, engages in the development, manufacture ... diagnostic products. The,Company announced today that JPI,s ...
... 30 ADVENTRX Pharmaceuticals,Inc. (Amex: ANX ), ... proprietary product candidates for the treatment,of cancer and ... the,company,s current Chief Executive Officer, has resumed his ... he held from September,2004 through September 2006., ...
... Angiotech Pharmaceuticals,Inc. (NASDAQ: ANPI , TSX: ANP), ... scheduled to participate in the Merrill Lynch,Global Pharmaceutical, ... February 5-7 in New York, NY., Dr. ... scheduled to present on Tuesday, February 5, at ...
Cached Biology Technology:AMDL Wins Chinese Military Supply Agreement for Its Domperidone Product for up to $6.6 Million 2ADVENTRX Announces Consolidation of Clinical and Management Positions 2ADVENTRX Announces Consolidation of Clinical and Management Positions 3
(Date:2/5/2015)... Jan. 28, 2015 NXT-ID, Inc. (NASDAQ: ... a biometric authentication company focused on the growing mobile ... RedChip Global Online CEO Conference on January 29 th ... Gino Pereira , CEO of NXT-ID will present and ... the Wocket smart wallet and its full suite of ...
(Date:1/22/2015)... , Jan. 22, 2015 Research and Markets ... "Biometrics - A Global Market Overview" report to their ... technology is to ensure that an individual is who she/he ... may make use of a person,s unique physical characteristics, such ...
(Date:1/22/2015)... Hall E -   EyeLock Inc. , a market leader ... its EyeLock ID technology integrated in a 3D printed automobile ... Ridge National Laboratory (ORNL) at the 2015 North ... is being used to validate the driver and authorize the ...
Breaking Biology News(10 mins):CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3
... 13, 2013  Medbox, Inc. (OTC Markets: MDBX) ( www.medboxinc.com ... in and entered into a licensing agreement with Bio-Tech ... to record earnings of 25% at a minimum and ... involvement in the revenue generating deals for Bio-Tech. Bio-Tech ...
... and yet it,s largely unknown how they manage to be ... reproduction, but until now have known little of how successful ... found new colonies. For the first time, Stanford biologists ... own children in wild ant colonies, making it possible to ...
... Cities around the world can significantly reduce greenhouse gas ... says a new study by University of Toronto Civil ... specialist Lorraine Sugar, one of Kennedy,s former students. ... carbon infrastructure plan for Toronto, Canada, published in the ...
Cached Biology News:Medbox Partners with Bio-Tech Medical Software to Create Nation's Safest Prescription Drug and Medical Marijuana Distribution System 2Medbox Partners with Bio-Tech Medical Software to Create Nation's Safest Prescription Drug and Medical Marijuana Distribution System 3Medbox Partners with Bio-Tech Medical Software to Create Nation's Safest Prescription Drug and Medical Marijuana Distribution System 4Stanford scientist uncovers the reproductive workings of a harvester ant dynasty 2Cities can reduce greenhouse gas emissions by 70 percent, says U of T researcher 2
RABBIT ANTI AMPHOTERIN...
Amino Acid Analysis is performed using ion-exchange separation of the amino acids from acid hydrolysates, followed by ninhydrin detection. Typical quantities required are 0.1 to 0.5 mg, depending on...
... Edited by R. Edwards ... on all types of immunoassays, ... surface immunoassays and on the ... immunoassays. Essential information is also ...
... kit contains the basic components required for ... natural and recombinant Feline IL-10 in cell ... sufficient materials to run ELISAs on approximately ... conditions are met: The assay is ...
Biology Products: